Key Financial Data Of Group

KYORIN Pharmaceutical Co., Ltd. - Filing #7594844

Concept 2022-04-01 to
2022-06-30
As at
2022-06-30
2021-04-01 to
2022-03-31
As at
2022-03-31
As at
2021-06-30
2021-04-01 to
2021-06-30
Key financial data of group
Business results of group
Net sales
24,619,000,000 JPY
105,534,000,000 JPY
24,695,000,000 JPY
Ordinary profit (loss)
779,000,000 JPY
5,569,000,000 JPY
-491,000,000 JPY
Profit (loss) attributable to owners of parent
1,183,000,000 JPY
3,932,000,000 JPY
-462,000,000 JPY
Comprehensive income
2,367,000,000 JPY
3,625,000,000 JPY
-965,000,000 JPY
Net assets
125,014,000,000 JPY
124,507,000,000 JPY
121,080,000,000 JPY
Total assets
171,001,000,000 JPY
171,924,000,000 JPY
163,555,000,000 JPY
Basic earnings (loss) per share
20.65
68.62
-8.06
Diluted earnings per share
Equity-to-asset ratio
0.731 xbrli:pure
0.724 xbrli:pure
0.740 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.